Prevention and treatment of NSAID-induced gastroduodenal injury (Q28195728)

Crossref

https://api.crossref.org/works/10.1007%2FS11938-006-0033-4

Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11938-006-0033-4

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11938-006-0033-4

Toxicity of NSAIDs in the stomach and duodenum

21 January 2018

1 reference

12 December 2020

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin

1 reference

12 December 2020

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

1 reference

12 December 2020

Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases

1 reference

12 December 2020

Review article: appropriate use of proton pump inhibitors with traditional nonsteroidal anti-inflammatory drugs and COX-2 selective inhibitors

1 reference

12 December 2020

Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract

1 reference

12 December 2020

Cardioprotective effects and gastrointestinal risks of aspirin: maintaining the delicate balance

1 reference

12 December 2020

A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use

1 reference

12 December 2020

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

12 December 2020

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

12 December 2020

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

12 December 2020

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

1 reference

12 December 2020

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding

1 reference

12 December 2020

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

1 reference

12 December 2020

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

12 December 2020

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

1 reference

12 December 2020

Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding

1 reference

12 December 2020

Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

1 reference

12 December 2020

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

1 reference

12 December 2020

Estrategia clínica para la prevención de los efectos adversos sobre el tracto digestivo de los antiinflamatorios no esteroideos

1 reference

12 December 2020

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

1 reference

12 December 2020

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug gastropathy

1 reference

12 December 2020

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

12 December 2020

Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

1 reference

12 December 2020

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

1 reference

12 December 2020

Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors

1 reference

12 December 2020

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

12 December 2020

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

1 reference

12 December 2020

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

12 December 2020

Low-dose aspirin for the prevention of atherothrombosis

1 reference

12 December 2020

Underutilization of preventive strategies in patients receiving NSAIDs

1 reference

12 December 2020

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

12 December 2020

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

1 reference

12 December 2020

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo

1 reference

12 December 2020

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

1 reference

12 December 2020

10.1007/S11938-006-0033-4

Identifiers

DOI

0 references

Fatcat ID

release_bwrwcv7cyjbmjd6jhdjzbl72iu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bwrwcv7cyjbmjd6jhdjzbl72iu

24 November 2022